Literature DB >> 17574683

First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia.

Kathleen Crebbin1, Emma Mitford, Roger Paxton, Douglas Turkington.   

Abstract

BACKGROUND: Compared with non-psychotic depression, psychotic depression is associated with poor prognosis, increased mortality, and severe symptomatology. Although the incidence of psychotic depression is similar to that of schizophrenia, little is known about presentation, course, costs and effects of treatment. AIMS: To compare the incidence, course and treatment of first-episode psychotic depression with first-episode schizophrenia.
METHOD: An observational database was set up on all patients aged 16 and over with a first-episode psychosis living in a county in Northern England between October 1998 and October 2005. Data were collected at presentation and annual follow-up. Information on patients with an ICD-10 diagnosis of either psychotic depression (F32.3) or schizophrenia (F20) was compared.
RESULTS: Between 1998 and 2005 there was a higher incidence of psychotic depression than schizophrenia (p<0.05, 95% CI=1.09, 1.89, RR=1.44). More patients with psychotic depression self-harmed (p<0.01) and had physical health problems (p<0.01). Similar levels of hospitalisation were found in both groups. A consistent pharmacological treatment pattern was observed for patients with psychotic depression but only 18 out of 105 received ECT. All who received ECT responded well to this treatment. LIMITATIONS: Data collection relied on information in patients' medical notes, which sometimes had gaps. There is a potential under-representation of patient numbers due to the study relying on referral by consultant psychiatrists.
CONCLUSIONS: Psychotic depression is a common and costly condition, but with no accepted best practice guidance for its management. More attention needs to be focused on this largely under-researched group.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574683     DOI: 10.1016/j.jad.2007.04.025

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

Review 1.  Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review.

Authors:  Geraldo F Busatto
Journal:  Schizophr Bull       Date:  2013-04-24       Impact factor: 9.306

2.  Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Olabisi Owoeye; Tara Kingston; Paul J Scully; Patrizia Baldwin; David Browne; Anthony Kinsella; Vincent Russell; Eadbhard O'Callaghan; John L Waddington
Journal:  Schizophr Bull       Date:  2013-05-28       Impact factor: 9.306

Review 3.  Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses.

Authors:  James B Kirkbride; Antonia Errazuriz; Tim J Croudace; Craig Morgan; Daniel Jackson; Jane Boydell; Robin M Murray; Peter B Jones
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

4.  Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients.

Authors:  M Heslin; J M Lappin; K Donoghue; B Lomas; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; G A Doody; P Dazzan; T J Craig; C Morgan
Journal:  Schizophr Res       Date:  2016-05-26       Impact factor: 4.939

5.  Drug and alcohol misuse in first episode psychosis: An observational study.

Authors:  Kathleen Crebbin; Emma Mitford; Roger Paxton; Douglas Turkington
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570

6.  Biological and psychosocial risk factors for psychotic major depression.

Authors:  M Heslin; R Desai; J M Lappin; K Donoghue; B Lomas; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; G A Doody; P Dazzan; H L Fisher; A Demjaha; T Craig; C Morgan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-10-31       Impact factor: 4.328

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.